The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlus500 Regulatory News (PLUS)

Share Price Information for Plus500 (PLUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,210.00
Bid: 2,202.00
Ask: 2,206.00
Change: 16.00 (0.73%)
Spread: 4.00 (0.182%)
Open: 2,200.00
High: 2,210.00
Low: 2,184.00
Prev. Close: 2,194.00
PLUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Results

2 May 2023 15:34

RNS Number : 1619Y
Plus500 Limited
02 May 2023
 

2 May 2023

Plus500 Ltd.

 

("Plus500", the "Company" or together with its subsidiaries the "Group")

AGM Results

Plus500, a global multi‐asset fintech group operating proprietary technology‐based trading platforms, announces the results of resolutions proposed at today's Annual General Meeting ("AGM").

Each of the resolutions proposed were voted on by way of a poll. All but one of the resolutions (namely resolution 22, which was an advisory vote) were passed by the requisite majorities. For information, the full results of the poll are set out below:

Resolutions

For

% Votes cast

Against

% Votes cast

Vote Withheld

Total Votes Cast (excl. Votes Withheld)

% of issued share capital*

1. Re‐elect David Zruia

42,020,540

98.19

774,890

1.81

831,508

42,795,430

46.73

2. Re‐elect Elad Even‐Chen

42,610,879

97.67

1,015,771

2.33

288

43,626,650

47.63

3. Re‐elect Steve Baldwin

30,677,514

70.32

12,949,136

29.68

288

43,626,650

47.63

4. Re‐elect Sigalia Heifetz

35,994,467

82.51

7,632,183

17.49

288

43,626,650

47.63

5. Re‐elect Varda Liberman

43,165,431

98.94

461,219

1.06

288

43,626,650

47.63

6. Re‐elect Jacob A. Frenkel

42,045,603

96.38

1,581,047

3.62

288

43,626,650

47.63

7. Re‐appoint the auditors

42,929,992

98.40

696,839

1.60

107

43,626,831

47.63

8. Authorise

Board to fix

remuneration of auditors

41,908,004

96.06

1,718,827

3.94

107

43,626,831

47.63

9. Authorise issue of equity

42,792,540

98.09

834,291

1.91

107

43,626,831

47.63

10. Authorise issue of equity for acquisitions

42,608,890

97.67

1,017,941

2.33

107

43,626,831

47.63

11. Purchase own shares

42,556,430

97.91

908,402

2.09

162,106

43,464,832

47.46

12. Approve

increase in fees to Anne Grim

43,623,690

99.99

317

0.01

2,931

43,624,007

47.63

13. Approve

increase in fees to Tami Gottlieb

43,623,690

99.99

317

0.01

2,931

43,624,007

47.63

14. Approve

increase in fees

to Steve Baldwin

43,623,690

99.99

317

0.01

2,931

43,624,007

47.63

15. Approve

increase in fees

to Sigalia Heifetz

43,623,690

99.99

317

0.01

2,931

43,624,007

47.63

16. Approve increase in

fees to Varda Liberman

43,623,690

99.99

317

0.01

2,931

43,624,007

47.63

17. Approve increase in the remuneration of Jacob A. Frenkel

43,248,045

99.14

375,962

0.86

2,931

43,624,007

47.63

18. Allotment of shares to Jacob A. Frenkel

31,055,615

71.19

12,570,392

28.81

931

43,626,007

47.63

19. Approve new remuneration policy for Directors and Executives

33,649,668

77.03

10,031,990

22.97

14,048,052

43,681,658

47.69

20. Approve remuneration terms for David Zruia

33,827,996

77.44

9,853,769

22.56

14,047,945

43,681,765

47.69

21. Approve remuneration terms for Elad Even-Chen

35,067,407

80.38

8,557,431

19.62

2,100

43,624,838

47.63

22. Advisory vote ‐ Approve the Directors' Remuneration Report

10,819,053

25.02

32,426,555

74.98

381,330

43,245,608

47.22

To view the full wording of, and the votes required for, each of the resolutions, please refer to the Notice of 2023 Annual General Meeting which is available on the Company's website.

Votes withheld are not a vote in law and have not been counted in the calculation of the votes for and against the resolution, the total votes validly cast or the calculation of the proportion of issued share capital voted.

The Board of Plus500 notes that 20% or more of votes were cast against the Board's recommendation for five resolutions. The Board takes these votes very seriously and will continue to engage with shareholders and shareholder advisory bodies to ensure their feedback informs the Company's future approach to governance and remuneration. In accordance with the UK Corporate Governance Code, an update on the views received from shareholders and the actions taken will be published by Plus500 during the next six months. The Board remains fully committed to achieving high governance standards, while recognising the importance of providing the appropriate incentives to the Group's Board and Executive management, who continue to drive the value of Plus500's business for shareholders.

Listing Rule 9.6.2 and total voting rights

In accordance with Listing Rule 9.6.2, copies of the resolutions that were passed at the annual general meeting, which do not constitute ordinary business will shortly be available for inspection via the National Storage Mechanism:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

*As at 28 March 2023, the day on which shareholders had to be on the register in order to be eligible to vote, the number of Ordinary Shares of NIS 0.01 in issue, entitling the holders to vote on all the resolutions at the AGM, was 91,585,997 (excluding treasury shares), and the Company held 23,302,380 Ordinary Shares in treasury.

The voting poll results are available on the Company's website at www.plus500.com.

For further details

 

Plus500 Ltd.

Elad Even-Chen, Chief Financial Officer

 

+972 4 8189503

ir@Plus500.com

Dentons Global Advisors

James Melville-Ross

James Styles

Leah Dudley

+44 (0)20 7664 5095

plus500@dentonsglobaladvisors.com

 

About Plus500

 

Plus500 is a global multi-asset fintech group operating proprietary technology-based trading platforms. Plus500 offers customers a range of trading products, including OTC ("Over-the-Counter" products, namely Contracts for Difference (CFDs)), share dealing, as well as futures and options on futures. The Group retains operating licences and is regulated in the United Kingdom, Australia, Cyprus, Israel, New Zealand, South Africa, Singapore, the Seychelles, the United States, Estonia, Japan and the UAE and through its OTC product portfolio, offers more than 2,500 different underlying global financial instruments, comprising equities, indices, commodities, options, ETFs, foreign exchange and cryptocurrencies. Customers of the Group can trade its OTC products in more than 50 countries and in 30 languages. Plus500 does not permit customers located in the US to trade its OTC products. Plus500 does not utilise cold calling techniques and does not offer binary options. Plus500's trading platforms are accessible from multiple operating systems (Windows, iOS and Android) and web browsers. Customer care is and has always been integral to Plus500, as such, OTC customers cannot be subject to negative balances. A free demo account is available on an unlimited basis for OTC trading platform users and sophisticated risk management tools are provided free of charge to manage leveraged exposure and stop losses to help customers protect profits, while limiting capital losses. Plus500 shares have a premium listing on the Main Market of the London Stock Exchange (symbol: PLUS) and are a constituent of the FTSE 250 index. www.plus500.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGNKBBNQBKDNPK
Date   Source Headline
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSQ1 2024 Trading Update
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNS2023 Annual Report and 2024 Annual General Meeting
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.